论文部分内容阅读
结核短程化疗,是现代化疗最有前途的治疗方案,可获得与标化一年半疗程的同样疗效。现将我科1982~1986年初、资料完整、疗程满6个月的103例病人治疗结果分述于后。对象与方法一、对象选例标准:未用过抗痨药或用抗痨药不超过一个月;痰菌阳性或阴性;肺部有活动病变或有空洞的初治肺结核病人;年龄在16岁以上。肝肾功能正常,无其它重要合并症(糖尿病、尘肺、肺外结核等)及过敏体质者。依照上述条件,选择115例,除因某些原因中
Tuberculosis short-course chemotherapy is the most promising treatment of modern chemotherapy, available with the standard one and a half courses of the same effect. Now our department from 1982 to early 1986, the data is complete, the course of 6 months of treatment of 103 patients are described in the results. Subjects and methods First, the object selection criteria: no anti-tuberculosis drugs or anti-tuberculosis drugs with no more than one month; sputum positive or negative; lung lesions or empty first-onset tuberculosis patients; aged 16 years the above. Liver and kidney function is normal, no other important complications (diabetes, pneumoconiosis, extrapulmonary tuberculosis, etc.) and allergies. In accordance with the above conditions, select 115 cases, except for some reasons